| Development and validation of stability indicating HPLC methods for related substances and assay analyses of amoxicillin and potassium clavulanate mixtures EB Atici, Y Yazar, Ç Ağtaş, N Ridvanoğlu, B Karlığa Journal of Pharmaceutical and Biomedical Analysis 136, 1-9, 2017 | 30 | 2017 |
| Synthesis and characterization of oxitropium bromide related substances and novel stability indicating HPLC methods EB Atici, Ç Ağtaş, Y Yazar, N Rıdvanoğlu Journal of Pharmaceutical and Biomedical Analysis 183, 113145, 2020 | 7 | 2020 |
| Investigation of aclidinium bromide degradation by stability-indicating HPLC methods, characterization of impurities by NMR, and identification of degradation products by LC-MS Y Yazar, FGA Özel, EB Atici, E Yılmaz, İ Narin Journal of Pharmaceutical and Biomedical Analysis 238, 115845, 2024 | 2 | 2024 |
| Synthesis, characterization and control of eight process related and two genotoxic fingolimod impurities by a validated RP-UPLC method. EB Atici, Y Yazar, N Rıdvanoğlu Biomedical Chromatography: BMC, e5316-e5316, 2022 | 1* | 2022 |
| Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor T Demirhan, E Guksu, Y Yazar, E Keskin, EB Atici, SA Özkan Journal of Pharmaceutical and Biomedical Analysis 243, 116085, 2024 | | 2024 |
Esen Bellur AticiDEVA Holding A.Ş.E-mailová adresa ověřena na: deva.com.tr
